1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Fluvoxamine (maleate) |
| brand | String | Luvox (US brand discontinued; generic widely available), Luvox CR, Faverin (other markets) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:SSRIs|Selective serotonin reuptake inhibitor (SSRI)]] • [[:Category:Antidepressants|Antidepressant]] • [[:Category:Anxiolytics|Anxiolytic]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000001D-QINU`"', '"`UNIQ--vote-0000001E-QINU`"', '"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"' |
| starting_dose | String | 50 mg PO at bedtime; titrate by 50 mg every 4-7 days to clinical effect. Total daily doses >100 mg divided BID. Luvox CR: 100 mg PO once daily, may titrate to 300 mg/day |
| preparations | String | IR tablets 25, 50, 100 mg; Luvox CR capsules 100, 150 mg |
| fda_max | String | 300 mg/day (IR or CR) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | OCD effect over 1-2 weeks initial, with full effect typically 6-12 weeks; among the slowest SSRIs for OCD response |
| duration | String | BID at higher doses (IR); once-daily (CR) |
| halflife | String | ~15 hours (IR)'"`UNIQ--ref-00000023-QINU`"' |
| bioavailability | String | ~53% (oral)'"`UNIQ--ref-00000024-QINU`"' |
| pregnancy | String | Observational signal for neonatal adaptation syndrome with third-trimester exposure (SSRI class effect).<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US. Carries the antidepressant '''Boxed Warning''' for suicidality in children, adolescents, and young adults'"`UNIQ--ref-00000025-QINU`"' |
